ArticleJapanese journal of ophthalmology2026
Involvement of best-corrected visual acuity in sarcopenia: findings from baseline analysis of the Kyotango longevity cohort study.
Article in Japanese journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
purposeTo investigate the association between best-corrected visual acuity (BCVA) and sarcopenia in older adults, while the relationship between low visual acuity and age-related muscle decline remains unclear. STUDY
designCross-sectional study.
methodsThis cross-sectional study included 874 participants in the Kyotango Longevity Cohort Study from August 2017 to June 2022. We analyzed the association between best-corrected visual acuity (BCVA) and the presence of sarcopenia, grip strength, gait speed, and skeletal muscle index (SMI) in older adults. Logistic regression analyses were performed with sarcopenia as the dependent variable and visual acuity as the independent variable, adjusted for age, sex, body mass index (BMI), HbA1c, smoking, exercise, and alcohol consumption. Decimal BCVA was converted to the logarithm of the minimum angle of resolution (logMAR) for statistical analyses.
resultsThis cross-sectional study comprised 356 men and 518 women, with a median age of 72.0 years (range: 65-98 years). The prevalence of sarcopenia was 6.7% (24 cases) in the men and 5.2% (27 cases) in the women. Multivariate logistic regression analysis revealed a significant association between low visual acuity and sarcopenia for both sexes [odds ratio: 1.86, 95% confidence interval (CI): 1.23-2.81, p = 0.002 for men, and odds ratio: 1.45, 95% CI: 1.01-2.02, p = 0.038 for women).
conclusionsThis study demonstrates a significant relationship between lower visual acuity and sarcopenia. These findings support maintaining visual acuity to prevent age-related decline of physical functions.
Indexed as
Identifiers
41269445What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.